BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10462962)

  • 1. [Surgical treatment of polycystic ovary syndrome].
    Warenik-Szymankiewicz A; Grotowski W; Halerz-Nowakowska B; Maciejewska M
    Ginekol Pol; 1999 May; 70(5):269-74. PubMed ID: 10462962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Circulating free-testosterone and SHBG levels before and after ovarian wedge resection in patients with polycystic ovarian disease].
    Oikawa M; Tanaka T; Ohkochi T; Yamamoto R; Sakuragi N; Fujimoto S; Ichinoe K
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Apr; 39(4):689-90. PubMed ID: 3585114
    [No Abstract]   [Full Text] [Related]  

  • 3. [Surgical treatment of polycystic ovary syndrome. A. Preoperative examinations].
    Baron J; Szymański W; Warenik-Szymankiewicz A; Zmich C; Baron JJ
    Ginekol Pol; 1992 Apr; 63(4):181-6. PubMed ID: 1303925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone levels following wedge resection in polycystic ovary syndrome.
    Mahesh VB; Toledo SP; Mattar E
    Obstet Gynecol; 1978 Jan; 51(1 Suppl):64s-69s. PubMed ID: 144874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome.
    Judd HL; Rigg LA; Anderson DC; Yen SS
    J Clin Endocrinol Metab; 1976 Aug; 43(2):347-55. PubMed ID: 950366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma androgens and sex hormone binding globulin in women with polycystic ovaries diagnosed by transvaginal ultrasound.
    Yoshino K; Takahashi K; Eda Y; Okada S; Kitao M
    J Reprod Med; 1993 Nov; 38(11):858-62. PubMed ID: 8277481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating gonadotropins and ovarian adiponectin system are modulated by acupuncture independently of sex steroid or β-adrenergic action in a female hyperandrogenic rat model of polycystic ovary syndrome.
    Maliqueo M; Benrick A; Alvi A; Johansson J; Sun M; Labrie F; Ohlsson C; Stener-Victorin E
    Mol Cell Endocrinol; 2015 Sep; 412():159-69. PubMed ID: 25963796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of oral contraceptives on anthropomorphometric, endocrine, and metabolic profiles of anovulatory polycystic ovary syndrome patients.
    Mes-Krowinkel MG; Louwers YV; Mulders AG; de Jong FH; Fauser BC; Laven JS
    Fertil Steril; 2014 Jun; 101(6):1757-65.e1. PubMed ID: 24680368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Circulating levels of LH, FSH and basal steroids in subjects with polycystic ovary syndrome before and after wedge resection of the ovaries].
    Ragucci N; Amato G; Izzo A
    Arch Ostet Ginecol; 1981; 86(5-6):263-79. PubMed ID: 6819842
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum LH and FSH levels in women with polycystic ovary syndrome before and after ovarian wedge resection.
    Shterev AD; Dokumov SI
    Endocrinologie; 1982; 20(3):203-7. PubMed ID: 6815773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of patients with typical forms of polycystic ovaries].
    El'tsov-Strelkov VI; Orlova VG; Grozovskaia LV
    Akush Ginekol (Mosk); 1985 Feb; (2):11-3. PubMed ID: 3158218
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnostic criteria for polycystic ovary syndrome].
    Dolian GG; Burnazian RA; Vanetsian AL; Okoev GG; Abgarian MT
    Akush Ginekol (Mosk); 1989 Jul; (7):26-8. PubMed ID: 2529789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ovarian wedge resection for polycystic ovary syndrome: analysis of 28 cases].
    Zhu RL
    Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):290-3, 319. PubMed ID: 3936686
    [No Abstract]   [Full Text] [Related]  

  • 14. The relation between obesity and testosterone-estradiol binding globulin levels in polycystic ovarian syndrome (PCO).
    Badawy SZ; Weigert JM; Marshall LD; Cuenca VG
    Diagn Gynecol Obstet; 1980; 2(1):43-6. PubMed ID: 7193560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual life of women with the Stein-Leventhal syndrome.
    Raboch J; Kobilková J; Raboch J; Stárka L
    Arch Sex Behav; 1985 Jun; 14(3):263-70. PubMed ID: 3924004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter re: The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance.
    Puder JJ; Müller B; Keller U
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4419-20. PubMed ID: 16002415
    [No Abstract]   [Full Text] [Related]  

  • 17. Menstrual irregularity in the first postmenarchal years: an early clinical sign of polycystic ovary syndrome in adolescence.
    Avvad CK; Holeuwerger R; Silva VC; Bordallo MA; Breitenbach MM
    Gynecol Endocrinol; 2001 Jun; 15(3):170-7. PubMed ID: 11447727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal effects of flutamide in young women with polycystic ovary syndrome.
    De Leo V; Lanzetta D; D'Antona D; la Marca A; Morgante G
    J Clin Endocrinol Metab; 1998 Jan; 83(1):99-102. PubMed ID: 9435423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype.
    Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A
    Eur J Endocrinol; 2008 Jun; 158(6):861-5. PubMed ID: 18505907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome.
    Veldhuis JD; Pincus SM; Garcia-Rudaz MC; Ropelato MG; Escobar ME; Barontini M
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3772-8. PubMed ID: 11502810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.